Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: an overview

Area of Science:

• Cardiovascular Science
• Metabolic Disease Research
• Endothelial Function Studies

Background:

• Obesity significantly elevates the risk of cardiovascular and metabolic diseases.
• Obesity-induced endothelial dysfunction, evident even in children, impairs vascular control and blood flow.
• This dysfunction involves reduced nitric oxide (NO) production, increased oxidative stress, and elevated vasoconstrictors.

Purpose of the Study:

• To elucidate the mechanisms of obesity-induced endothelial dysfunction.
• To explore the role of adipokines and other factors in endothelial health.
• To review interventions for reversing obesity-related endothelial dysfunction.

Main Methods:

• Analysis of mechanisms including nitric oxide synthase (NOS) activity, superoxide production, and ADMA levels.
• Investigation of vasoconstrictor factors like endothelin-1 and sympathetic activation.
• Review of the impact of endothelial progenitor cells, insulin resistance, and adipokines (adiponectin, ghrelin, leptin).

Main Results:

• Obesity impairs endothelial function through decreased NO bioavailability and increased vasoconstriction.
• Insulin resistance, diabetes, and reduced endothelial progenitor cells exacerbate dysfunction.
• Adipokines like adiponectin and ghrelin show protective effects, while leptin's role is debated.

Conclusions:

• Weight reduction through exercise, diet, or surgery effectively improves endothelial function in obesity.
• Pharmacological agents targeting pathways like NADPH oxidase and beta-adrenergic receptors may offer adjunctive benefits.
• Comprehensive management combining lifestyle changes with targeted therapies is crucial for restoring endothelial health.